Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.45 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.43 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.39 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 4/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22389338 | 1.00 | KDM4C (0.45) | KDM4CNR3C1KDM2BMTNR1AMTNR1B | |
| SCHEMBL22389127 | 0.83 | KDM2B (0.42) | NR3C1KDM2BMTNR1AMTNR1BNQO2 | |
| SCHEMBL24593623 | 0.81 | KDM4C (0.46) | KDM4CNR3C1KDM2BMTNR1AMTNR1B | |
| SCHEMBL15839921 | 0.81 | HTR6 (0.54) | KDM4CHTR6HTR2AHTR2CKDM1A | |
| SCHEMBL22389339 | 0.80 | MTNR1A (0.61) | MTNR1AMTNR1BNQO2TRPV1 | |
| SCHEMBL18988728 | 0.80 | MTNR1A (0.61) | MTNR1AMTNR1BNQO2TRPV1 | |
| Hydrochloric Acid SCHEMBL6076988 | 0.78 | KDM4C (0.45) | KDM4CKDM2BMTNR1AMTNR1BNQO2 | |
| Hydrochloric Acid SCHEMBL6076996 | 0.78 | KDM4C (0.45) | KDM4CNR3C1KDM2BMTNR1AMTNR1B | |
| SCHEMBL31028096 | 0.77 | KDM4C (0.44) | KDM4CNR3C1KDM2BMTNR1AMTNR1B | |
| SCHEMBL8780415 | 0.76 | KDM4C (0.54) | KDM4CNR3C1MTNR1AMTNR1BNQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10995043-B2 | Method for producing perfluoroalkylated compound | RIKEN (JP) | 2021-05-04 | — | — | US | disclosed |
| US-10995043-B2 | Method for producing perfluoroalkylated compound | RIKEN (JP) | 2021-05-04 | — | — | US | disclosed |
| US-20200277243-A1 | METHOD FOR PRODUCING PERFLUOROALKYLATED COMPOUND | RIKEN (JP) | 2020-09-03 | — | — | US | disclosed |
| US-20200277243-A1 | METHOD FOR PRODUCING PERFLUOROALKYLATED COMPOUND | RIKEN (JP) | 2020-09-03 | — | — | US | disclosed |
| EP-3392228-A1 | METHOD FOR PRODUCING PERFLUOROALKYLATED COMPOUND | RIKEN (JP) | 2018-10-24 | — | — | EP | disclosed |
| WO-2017104589-A1 | METHOD FOR PRODUCING PERFLUOROALKYLATED COMPOUND | 国立研究開発法人理化学研究所 | 2017-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10995043-B2 | Method for producing perfluoroalkylated compound | PAOX, PPOX, GPX4 | KDM4C 2742/4885NR3C1 2847/4885KDM2B 2850/4885 |
| US-20200277243-A1 | METHOD FOR PRODUCING PERFLUOROALKYLATED COMPOUND | PAOX, PPOX, GPX4 | KDM4C 2742/4885NR3C1 2847/4885KDM2B 2850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.